Cooper EBITDA 2010-2024 | COO

Cooper EBITDA for the quarter ending July 31, 2024 was $0.282B, a 14.38% increase year-over-year.

  • Cooper 2023 EBITDA was 0.901B, a 5.52% increase from 2022.
  • Cooper 2022 EBITDA was 0.854B, a 4.74% increase from 2021.
  • Cooper 2021 EBITDA was 0.815B, a 36.1% increase from 2020.

EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.

Cooper EBITDA 2010-2024 | COO

  • Cooper 2023 EBITDA was 0.901B, a 5.52% increase from 2022.
  • Cooper 2022 EBITDA was 0.854B, a 4.74% increase from 2021.
  • Cooper 2021 EBITDA was 0.815B, a 36.1% increase from 2020.

EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.
Related Stocks
Company NameMarket
Cap
McKesson (MCK)$79.1B
Becton Dickinson (BDX)$64.7B
Cardinal Health (CAH)$29.5B
West Pharmaceutical Services (WST)$22.9B
Labcorp (LH)$20B
Align Technology (ALGN)$16.9B
Henry Schein (HSIC)$9.4B
Merit Medical Systems (MMSI)$6.1B
DENTSPLY SIRONA (XRAY)$3.7B
CONMED (CNMD)$2.3B
Patterson (PDCO)$1.8B
STAAR Surgical (STAA)$1.3B
Lifevantage (LFVN)$178M
Pro-Dex (PDEX)$152M